Referring to these studies, CRH-R2 antagonists reversed the CRH-induced increase in jejunal motility and colonic permeability and prevented C. difficile toxin A-induced enteritis as well as ischemia-induced hemorrhagic intestinal lesions, bacterial invasion, and macrophage inflammatory phenotype [24,35,55,65]. The gene discussed is CRH; the disease is enteritis.